Related Experiment Video
Updated: May 20, 2026
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment
Maria Volkova1, Raymond Russell
1Section of Cardiovascular Medicine, Yale University School of Medicine, USA.
Current Cardiology Reviews
|July 5, 2012
Summary
Anthracyclines are vital chemotherapy drugs, but they can cause dose-dependent heart damage leading to heart failure. This review covers how to detect, prevent, and treat this serious side effect.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Anthracyclines (e.g., doxorubicin, idarubicin) are essential chemotherapy agents.
- Their use is limited by cumulative dose-dependent cardiotoxicity.
- This cardiotoxicity can result in irreversible heart failure.
Purpose of the Study:
- To review the pathogenesis of anthracycline-induced cardiotoxicity.
- To discuss the incidence of this adverse effect.
- To outline current and potential methods for detection, prevention, and treatment.
Main Methods:
- Literature review of existing studies on anthracycline-induced cardiotoxicity.
- Synthesis of information regarding mechanisms, risk factors, and clinical outcomes.
- Compilation of data on diagnostic and therapeutic strategies.
Main Results:
- Anthracycline-induced cardiotoxicity is a significant concern in cancer treatment.
- Mechanisms involve oxidative stress, mitochondrial dysfunction, and DNA damage.
- Early detection and preventative measures are crucial for managing cardiotoxicity.
Conclusions:
- Anthracycline-induced cardiotoxicity is a serious, dose-dependent complication.
- Understanding pathogenesis is key to developing effective interventions.
- Multifaceted approaches are needed for detection, prevention, and treatment to improve patient outcomes.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...